• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.在地方性甲状腺肿地区,贝塞斯达Ⅴ级细胞学检查的患者中,中央区阳性淋巴结的诊断不足。
Gland Surg. 2020 Apr;9(2):252-260. doi: 10.21037/gs.2020.02.07.
2
Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels.对于因细针穿刺活检证实其他区域有转移而接受侧颈清扫术的甲状腺乳头状癌患者,常规清扫II - B和V - A区域是否必要?
World J Surg. 2009 Aug;33(8):1680-3. doi: 10.1007/s00268-009-0071-x.
3
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
4
Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为 Bethesda 类别 III(AUS/FLUS)的患者手术后的结果。
Endokrynol Pol. 2021;72(2):143-144. doi: 10.5603/EP.a2021.0018. Epub 2021 Mar 22.
5
Level IIb neck dissection guided by fine-needle aspiration for N1b papillary thyroid carcinoma.超声引导下细针穿刺活检 N1b 期甲状腺乳头状癌行 IIb 区颈部淋巴结清扫术。
Surg Oncol. 2022 Mar;40:101705. doi: 10.1016/j.suronc.2021.101705. Epub 2021 Dec 30.
6
Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.Bethesda III 和 IV 甲状腺结节的恶性率:细针穿刺细胞学与组织病理学相关性的回顾性研究。
BMC Endocr Disord. 2020 Apr 15;20(1):48. doi: 10.1186/s12902-020-0530-9.
7
The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage.贝塞斯达分类法在预测甲状腺乳头状癌分期中的效用及其与BRAF突变的关联。
Langenbecks Arch Surg. 2017 Mar;402(2):227-234. doi: 10.1007/s00423-017-1560-2. Epub 2017 Feb 3.
8
BRAF mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.甲状腺结节细针抽吸标本 BRAF 基因突变检测:4600 例患者的临床相关性。
Cancer Med. 2022 Jan;11(1):40-49. doi: 10.1002/cam4.4419. Epub 2021 Dec 1.
9
Correlation of thyroid fine-needle aspiration with final histopathology: a case series.甲状腺细针穿刺与最终组织病理学的相关性:病例系列
Minerva Chir. 2013 Apr;68(2):191-7.
10
Positive cytology findings and a negative histological diagnosis of papillary thyroid carcinoma in the thyroid: is it a false-positive cytology or a disappearing tumor?甲状腺中细胞学阳性发现和组织学阴性的甲状腺乳头状癌诊断:是假阳性细胞学还是消失的肿瘤?
Eur Thyroid J. 2013 Sep;2(3):203-10. doi: 10.1159/000353624. Epub 2013 Aug 13.

本文引用的文献

1
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017年甲状腺细胞病理学报告贝塞斯达系统
J Am Soc Cytopathol. 2017 Nov-Dec;6(6):217-222. doi: 10.1016/j.jasc.2017.09.002. Epub 2017 Sep 14.
2
Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease.甲状腺乳头状癌的淋巴结转移及其在疾病复发中的重要性。
Med Arch. 2018 Apr;72(2):108-111. doi: 10.5455/medarh.2018.72.108-111.
3
Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.第八版甲状腺癌肿瘤-淋巴结-转移分期系统中 N1b 分类的预后意义。
Thyroid. 2018 Apr;28(4):496-503. doi: 10.1089/thy.2017.0473. Epub 2018 Apr 5.
4
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.分化型和间变性甲状腺癌:美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2018 Jan;68(1):55-63. doi: 10.3322/caac.21439. Epub 2017 Nov 1.
5
Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature.对于初始治疗的cN0分化型甲状腺癌患者,预防性中央区颈部淋巴结清扫是否必要?一项文献荟萃分析。
Acta Otorhinolaryngol Ital. 2017 Feb;37(1):1-8. doi: 10.14639/0392-100X-1195.
6
Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.甲状腺超声引导下细针穿刺细胞学检查结果:过去十年间不确定率呈上升趋势。
Otolaryngol Head Neck Surg. 2017 Apr;156(4):611-615. doi: 10.1177/0194599816688190. Epub 2017 Jan 24.
7
The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer.预防性中央区颈淋巴结清扫术对甲状腺全切除术后甲状腺乳头状癌局部区域复发的影响:一项系统评价和荟萃分析:预防性中央区颈淋巴结清扫术与甲状腺乳头状癌局部区域复发
Ann Surg Oncol. 2017 Aug;24(8):2189-2198. doi: 10.1245/s10434-016-5691-4. Epub 2016 Dec 2.
8
Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.对于甲状腺乳头状癌,在全甲状腺切除术中常规进行中央区淋巴结清扫可能会将Ⅵ区复发风险降至最低。
Surgery. 2016 Oct;160(4):1049-1058. doi: 10.1016/j.surg.2016.06.042. Epub 2016 Aug 9.
9
Prophylactic "First-Step" Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy.预防性“第一步”中央区颈部清扫术(第6区)不会增加(全)甲状腺切除术后的发病率。
Ann Surg Oncol. 2016 Nov;23(12):4016-4022. doi: 10.1245/s10434-016-5338-5. Epub 2016 Jul 8.
10
Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.细针穿刺活检作为孤立性和多发性甲状腺结节恶性肿瘤患者的术前检查方法
PLoS One. 2016 Jan 19;11(1):e0146883. doi: 10.1371/journal.pone.0146883. eCollection 2016.

在地方性甲状腺肿地区,贝塞斯达Ⅴ级细胞学检查的患者中,中央区阳性淋巴结的诊断不足。

Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.

作者信息

Hargitai Lindsay, Strobl Stephanie, Koperek Oskar, Urach Susanne, Raber Wolfgang, Staudenherz Anton, Scheuba Christian, Riss Philipp

机构信息

Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.

Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.

出版信息

Gland Surg. 2020 Apr;9(2):252-260. doi: 10.21037/gs.2020.02.07.

DOI:10.21037/gs.2020.02.07
PMID:32420249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7225453/
Abstract

BACKGROUND

Fine needle aspiration (FNA) is a significant diagnostic procedure for detecting malignancy in patients with nodular thyroid disease. A high proportion of patients with cytological diagnosed follicular neoplasia (Bethesda IV and V) ultimately have thyroid cancer. The aim of this study was to evaluate the incidence of preoperatively undiagnosed central lymph node metastasis in patients with multinodular goiter (MNG).

METHODS

Patients who underwent FNA and were classified as Bethesda IV/V were included. Applying a radical approach, all patients underwent (hemi)thyroidectomy and prophylactic unilateral central neck dissection.

RESULTS

During our study period 2009-2013, 60 patients (19.7%) were classified as Bethesda IV and 21 (6.9%) Bethesda V. Final histopathological results revealed malignancy in 35 (43.2%) of 81 Bethesda IV/V nodules. Of the nodules classified as Bethesda IV, 20 (33.3%) showed malignancy in the final histology. Ten patients (16.7%) had papillary micro-carcinoma (mPTC, <10 mm), 4 (6.6%) PTC and 6 (10%) follicular thyroid cancer. Fifteen of 21 (71.4%) Bethesda V nodules were revealed as PTC of whom seven (33.3%) patients also had lymph-node metastases.

CONCLUSIONS

While 33.3% of the patients with PTC, preoperatively classified as Bethesda V, had previously undetected positive lymph-nodes, only one patient with Bethesda IV had lymph-node metastasis.

摘要

背景

细针穿刺抽吸活检(FNA)是检测结节性甲状腺疾病患者恶性肿瘤的重要诊断方法。细胞学诊断为滤泡性肿瘤(贝塞斯达IV级和V级)的患者中,很大一部分最终被诊断为甲状腺癌。本研究的目的是评估多结节性甲状腺肿(MNG)患者术前未诊断出的中央淋巴结转移的发生率。

方法

纳入接受FNA且分类为贝塞斯达IV/V级的患者。采用根治性手术方法,所有患者均接受(半)甲状腺切除术和预防性单侧中央区颈淋巴结清扫术。

结果

在我们2009年至2013年的研究期间,60例患者(19.7%)被分类为贝塞斯达IV级,21例患者(6.9%)为贝塞斯达V级。最终组织病理学结果显示,81个贝塞斯达IV/V级结节中有35个(43.2%)为恶性。在分类为贝塞斯达IV级的结节中,20个(33.3%)在最终组织学检查中显示为恶性。10例患者(16.7%)患有微小乳头状癌(mPTC,<10 mm),4例(6.6%)为PTC,6例(10%)为滤泡状甲状腺癌。21个贝塞斯达V级结节中有15个(71.4%)被诊断为PTC,其中7例(33.3%)患者也有淋巴结转移。

结论

术前分类为贝塞斯达V级的PTC患者中,33.3%先前未检测到阳性淋巴结,而贝塞斯达IV级患者中只有1例有淋巴结转移。